Emerging research shows mast cells play a role in the etiology of chronic rhinosinusitis with nasal polyps and may be a new ...

If that doesn't work, your doctor may give you a shot of a medicine called dupilumab (Dupixent). Unfortunately, nasal polyps tend to come back if the irritation, allergy, or infection continues.

The approval is based on a multi-center, randomized, double-blind, placebo-controlled phase III clinical study to confirm the efficacy and safety of Stapokibart injection in treatment of patients with ...

Nasal polyp surgery can provide significant relief for patients suffering from sinus-related issues. However, as expert ...

Since nasal polyps won’t go away on their own, treatment is essential to eliminate the danger and ensure cats can breathe easily. Removal by traction is a minor surgery veterinarians use to ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

The indication, I believe it is the most important to focus on, would be the use of verekitug for the treatment of patients with Chronic Rhinosinusitis with Nasal Polyps [CRSwNP]. The reason is ...

Health Canada has approved Omlyclo, the first omalizumab biosimilar in Canada, for the treatment of chronic idiopathic ...

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

"This study was the first to establish vitamin D deficiency as an independent risk factor for the incidence of endometrial ...

RAPT (RAPT) stock rallied as much as 180% Monday after the company announced a licensing deal with China's Jemincare and a $150M private placement of its stock. Read more here.

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved for the treatment of adults and adolescents with chronic idiopathic urticaria ...